|
Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body.
|
Shape Divider - Style triangle
DepYmed’s drug candidates target PTP1B as a new immune checkpoint. Elevated copper has been identified as a new dependency in tumor cells (Metalloplasia); DepYmed’s copper chelators bind copper specifically. DepYmed’s small molecule drugs allow us to target simultaneously the intracellular and extracellular environment of the tumor.
Shape Divider - Style triangle